At what enterprise value was IMV TECHNOLOGIES acquired in 2014?

During the acquisition of IMV TECHNOLOGIES by QUALIUM in 2014, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 100M - 350M EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of IMV TECHNOLOGIES when it was acquired by QUALIUM?

The estimated EV/EBITDA multiple for IMV TECHNOLOGIES is in the range of 5x - 12x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

When was IMV TECHNOLOGIES acquired by QUALIUM?

IMV TECHNOLOGIES was acquired by QUALIUM in 2014.

What was the revenue of IMV TECHNOLOGIES at the time of the deal?

The revenue of IMV TECHNOLOGIES at the time of the deal is estimated to be in the range of 50M - 100M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of IMV TECHNOLOGIES during the acquisition?

IMV TECHNOLOGIES's EBITDA is estimated to be in the range of 5M - 25M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the IMV TECHNOLOGIES acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the IMV TECHNOLOGIES deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://qualium-investissement.com/participation/imv-technologies/

← DATABASE

Home Database Healthcare & PharmaIMV TECHNOLOGIES

11/2014

IMV TECHNOLOGIES acquired by QUALIUM

FRANCE Life Sciences / Pharma & Biotech / R&D Biotech EV 100M - 350M EUR

Context

Qualium Investissement won the auction process to acquire IMV Technologies, beating competitors LBO France and Florac. This transaction ends the tenure of Pragma Capital (majority owner since 2010), as well as minority investors Cathay Capital and Eurazeo PME. The acquisition is supported by a unitranche debt facility provided by Ardian, representing a leverage of over 5.0x EBITDA. The strategic focus remains on international expansion.

It is worth noting that the fund Sparring Capital took control of Imv Technologies through an LBO in 2010.

IMV TECHNOLOGIES, which reported an EBITDA margin of in 2013, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

IMV Technologies is the world leader in reproduction biotechnologies for livestock (primarily bovine and porcine). The company designs and manufactures equipment and consumables (plastic straws) for artificial insemination. It holds a dominant position with over 50% global market share in bovine packaging. 85% of its revenue is generated internationally across 120 countries.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2013

2012

Other operations with IMV TECHNOLOGIES

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
01/2021	MONTAGU PRIVATE EQUITY	IMV TECHNOLOGIES	FRANCE	R&D Biotech
09/2010	SPARRING CAPITAL	IMV TECHNOLOGIES	FRANCE	R&D Biotech

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 50M - 100M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of IMV TECHNOLOGIES by QUALIUM are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: imv technologies

Acquirer: qualium